...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: BIO-Europe 11/7
2
Nov 06, 2017 10:52AM

Nov 07, 2017 09:58AM

Hartland,

I noticed that too, and expected the Zenith presentation to be up by now. Perhaps they will post both the Zenith and Resverlogix presentations at the same time (Resverlogix presents in ~40 minutes). If we don't see them up in the next hour, we can inquire with IR at Resverlogix and Zenith.

BearDownAZ

1
Nov 07, 2017 10:31AM

Nov 07, 2017 10:40AM
1
Nov 07, 2017 10:46AM

Nov 07, 2017 10:54AM
Share
New Message
Please login to post a reply